Your browser doesn't support javascript.
loading
Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAFV600E mutation.
Wang, Kai; Li, Yanrong; Song, Na; Che, Xiaofang; Hou, Kezuo; Xu, Ling; Bai, Ming; Wang, Qiwei; Wang, Yuanhe; Zhou, Yang; Cao, Meihui; Liu, Yunpeng; Zhang, Jingdong.
Affiliation
  • Wang K; Department of Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.
  • Li Y; Department of Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.
  • Song N; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
  • Che X; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
  • Hou K; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
  • Xu L; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
  • Bai M; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
  • Wang Q; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
  • Wang Y; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
  • Zhou Y; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
  • Cao M; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
  • Liu Y; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
  • Zhang J; Department of Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.
J Cell Biochem ; 120(4): 5315-5325, 2019 04.
Article in En | MEDLINE | ID: mdl-30320916
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms / Proto-Oncogene Proteins B-raf / STAT3 Transcription Factor / Vemurafenib Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: J Cell Biochem Year: 2019 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms / Proto-Oncogene Proteins B-raf / STAT3 Transcription Factor / Vemurafenib Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: J Cell Biochem Year: 2019 Type: Article Affiliation country: China